ADO and B-cell chronic lymphocytic leukemia: In the CLL field, Serra and co-authors demonstrated that extracellular ADO protects cells both from spontaneous and drug-induced apoptosis, in a range of concentrations compatible with that of CD73-mediated ADO generation by CLL cells.